Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094817510> ?p ?o ?g. }
- W2094817510 endingPage "E18" @default.
- W2094817510 startingPage "E18" @default.
- W2094817510 abstract "Object Currently, few medical options exist for refractory and atypical/anaplastic meningiomas. New developments in chemotherapeutic options for meningiomas have been explored over the past decade. The authors review these recent developments, with an emphasis on emerging avenues for therapy, clinical efficacy, and adverse effects. Methods A review of the literature was performed to identify any studies exploring recent medical and chemotherapeutic agents that have been or are currently being tested for meningiomas. Results from included preclinical and human clinical trials were reviewed and summarized. Results Current guidelines recommend only 3 drugs that can be used to treat patients with refractory and highgrade meningiomas: hydroxyurea, interferon-α 2B, and Sandostatin long-acting release. Recent developments in the medical treatment of meningiomas have been made across a variety of pharmacological classes, including cytotoxic agents, hormonal agents, immunomodulators, and targeted agents toward a variety of growth factors and their signaling cascades. Promising avenues of therapy that are being evaluated for efficacy and safety include antagonists of platelet-derived growth factor receptor, epidermal growth factor receptor, vascular endothelial growth factor receptor, and mammalian target of rapamycin. Because malignant transformation in meningiomas is likely to be mediated by numerous processes interacting via a complex matrix of signals, combination therapies affecting multiple molecular targets are currently being explored and hold significant promise as adjuvant therapy options. Conclusions Improved understanding of the molecular mechanisms driving meningioma tumorigenesis and malignant transformation has resulted in the targeted development of more specific agents for chemotherapeutic intervention in patients with nonresectable, aggressive, and malignant meningiomas." @default.
- W2094817510 created "2016-06-24" @default.
- W2094817510 creator A5035365137 @default.
- W2094817510 creator A5085362780 @default.
- W2094817510 creator A5087005813 @default.
- W2094817510 date "2013-12-01" @default.
- W2094817510 modified "2023-10-14" @default.
- W2094817510 title "Recent developments in chemotherapy for meningiomas: a review" @default.
- W2094817510 cites W1480755492 @default.
- W2094817510 cites W1544041971 @default.
- W2094817510 cites W1963483230 @default.
- W2094817510 cites W1963673993 @default.
- W2094817510 cites W1964633661 @default.
- W2094817510 cites W1964949700 @default.
- W2094817510 cites W1973762438 @default.
- W2094817510 cites W1976451653 @default.
- W2094817510 cites W1984545852 @default.
- W2094817510 cites W1985636377 @default.
- W2094817510 cites W1987792301 @default.
- W2094817510 cites W1989138467 @default.
- W2094817510 cites W1992610206 @default.
- W2094817510 cites W1994721067 @default.
- W2094817510 cites W2002015428 @default.
- W2094817510 cites W2004670730 @default.
- W2094817510 cites W2010278115 @default.
- W2094817510 cites W2010453590 @default.
- W2094817510 cites W2010629535 @default.
- W2094817510 cites W2010935776 @default.
- W2094817510 cites W2012784247 @default.
- W2094817510 cites W2013187784 @default.
- W2094817510 cites W2014319032 @default.
- W2094817510 cites W2014851190 @default.
- W2094817510 cites W2017520703 @default.
- W2094817510 cites W2021595176 @default.
- W2094817510 cites W2022977004 @default.
- W2094817510 cites W2025281994 @default.
- W2094817510 cites W2027675488 @default.
- W2094817510 cites W2027838880 @default.
- W2094817510 cites W2028209372 @default.
- W2094817510 cites W2029041840 @default.
- W2094817510 cites W2030223601 @default.
- W2094817510 cites W2033677092 @default.
- W2094817510 cites W2034972449 @default.
- W2094817510 cites W2037847243 @default.
- W2094817510 cites W2038057801 @default.
- W2094817510 cites W2040139345 @default.
- W2094817510 cites W2040473070 @default.
- W2094817510 cites W2051429797 @default.
- W2094817510 cites W2052028637 @default.
- W2094817510 cites W2055303161 @default.
- W2094817510 cites W2056819490 @default.
- W2094817510 cites W2060724712 @default.
- W2094817510 cites W2080027808 @default.
- W2094817510 cites W2081013078 @default.
- W2094817510 cites W2082209748 @default.
- W2094817510 cites W2089867969 @default.
- W2094817510 cites W2090169598 @default.
- W2094817510 cites W2096526848 @default.
- W2094817510 cites W2098953499 @default.
- W2094817510 cites W2102050281 @default.
- W2094817510 cites W2102448688 @default.
- W2094817510 cites W2103580195 @default.
- W2094817510 cites W2113317783 @default.
- W2094817510 cites W2115868832 @default.
- W2094817510 cites W2118328286 @default.
- W2094817510 cites W2123099447 @default.
- W2094817510 cites W2123783570 @default.
- W2094817510 cites W2126532897 @default.
- W2094817510 cites W2126765841 @default.
- W2094817510 cites W2127445947 @default.
- W2094817510 cites W2128725138 @default.
- W2094817510 cites W2140652292 @default.
- W2094817510 cites W2141007603 @default.
- W2094817510 cites W2146502430 @default.
- W2094817510 cites W2150419936 @default.
- W2094817510 cites W2150580529 @default.
- W2094817510 cites W2288693881 @default.
- W2094817510 cites W2294159125 @default.
- W2094817510 cites W2585431017 @default.
- W2094817510 cites W3189400240 @default.
- W2094817510 cites W4254297163 @default.
- W2094817510 cites W70732051 @default.
- W2094817510 doi "https://doi.org/10.3171/2013.10.focus13341" @default.
- W2094817510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24289126" @default.
- W2094817510 hasPublicationYear "2013" @default.
- W2094817510 type Work @default.
- W2094817510 sameAs 2094817510 @default.
- W2094817510 citedByCount "71" @default.
- W2094817510 countsByYear W20948175102014 @default.
- W2094817510 countsByYear W20948175102015 @default.
- W2094817510 countsByYear W20948175102016 @default.
- W2094817510 countsByYear W20948175102017 @default.
- W2094817510 countsByYear W20948175102018 @default.
- W2094817510 countsByYear W20948175102019 @default.
- W2094817510 countsByYear W20948175102020 @default.
- W2094817510 countsByYear W20948175102021 @default.
- W2094817510 countsByYear W20948175102022 @default.
- W2094817510 countsByYear W20948175102023 @default.